Ashley Pretorius
Overview
Explore the profile of Ashley Pretorius including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pheiffer C, Dias S, Mendham A, Jack B, Willmer T, Eshibona N, et al.
Sci Rep
. 2022 Nov;
12(1):18408.
PMID: 36319747
The mechanisms that underlie exercise-induced adaptations in adipose tissue have not been elucidated, yet, accumulating studies suggest an important role for microRNAs (miRNAs). This study aimed to investigate miRNA expression...
2.
Lombe C, Meyer M, Pretorius A
Mol Biotechnol
. 2021 Oct;
64(4):401-412.
PMID: 34665432
Prostate cancer (PCa) is the second most common form of cancer in men around the world. Due to its heterogeneity, presentations range from aggressive lethal disease to indolent disease. There...
3.
Bakare O, Keyster M, Pretorius A
Sci Rep
. 2021 Oct;
11(1):20621.
PMID: 34663864
Pneumonia is the main reason for mortality among children under five years, causing 1.6 million deaths every year; late research has exhibited that mortality is increasing in the elderly. A...
4.
Bakare O, Keyster M, Pretorius A
BMC Mol Cell Biol
. 2020 Nov;
21(1):82.
PMID: 33218302
Background: Pneumonia ranks as one of the main infectious sources of mortality among kids under 5 years of age, killing 2500 a day; late research has additionally demonstrated that mortality...
5.
Bakare O, Fadaka A, Keyster M, Pretorius A
Adv Appl Bioinform Chem
. 2020 Aug;
13:1-9.
PMID: 32821128
Introduction: Several studies have explored the design of antimicrobial peptides (AMPs) for the development of therapeutic and diagnostic molecules for the treatment and identification of pathogenic diseases as well as...
6.
Fadaka A, Bakare O, Pretorius A, Klein A
Tumour Biol
. 2020 Jun;
42(6):1010428320933512.
PMID: 32552466
Colorectal cancer is the second and third most common cancer in men and women, respectively, worldwide. Alterations such as genetic and epigenetic are common in colorectal cancer and are the...
7.
Tincho M, Morris T, Meyer M, Pretorius A
Int J Microbiol
. 2020 Apr;
2020:2131535.
PMID: 32322274
Many infectious diseases are still prevalent in the world's populations since no effective treatments are available to eradicate them. The reasons may either be the antibiotic resistance towards the available...
8.
Fadaka A, Klein A, Pretorius A
Tumour Biol
. 2019 Nov;
41(11):1010428319883721.
PMID: 31718480
The involvement of microRNA in cancers plays a significant role in their pathogenesis. Specific expressions of these non-coding RNAs also serve as biomarkers for early colorectal cancer diagnosis, but their...
9.
Fadaka A, Pretorius A, Klein A
Int J Mol Sci
. 2019 Oct;
20(20).
PMID: 31635135
Approximately 30-50% of malignant growths can be prevented by avoiding risk factors and implementing evidence-based strategies. Colorectal cancer (CRC) accounted for the second most common cancer and the third most...
10.
Fadaka A, Pretorius A, Klein A
Int J Mol Sci
. 2019 Oct;
20(19).
PMID: 31623294
Colorectal cancer (CRC) is the second-leading cause of cancer death and a major public health problem. Nearly 80% CRC cases are diagnosed after the disease have metastasized and are often...